When resources are scarce, cost-effectiveness estimates help make choices where to put the money for maximum health benefit.
New handguns, smuggled from Europe by car or in the post, are scarce and cost up to £500 ($1,000).
If you can find them in retail shops, Domaine de Chevalier runs about $50 to $60 a bottle, Laville $80 to $100 or so, while Haut-Brion blanc, which is much more scarce, can cost three times as much.
As other scaled media buying options become scarce, the cost of advertising on social media platforms will increase, leaving marketers disempowered and without a voice, too.
On the other hand, fine aggregates involved in the concrete are generally river sand, which is scarce, high cost and excavation of the river sand that promote environmental degradation.
This period of food insecurity generally occurs after the coffee harvest during the rainy season when access to food is scarce and costs increase.
With funds often being a scarce resource, costs can be minimized by finding speakers who will conduct the workshop for free, skipping the catering by instituting a "brown bag" format, and charging a small fee to cover any photocopying costs.
When resources are scarce and costs are rising fast, this would not be sustainable, and it means that somewhere someone else who can benefit more from the same resources will get excluded from coverage because we have exceeded our ability to pay.
In a world in which available resources become scarce and cost-benefit analyses are the cornerstone of healthcare policy, radiologists cannot sit back, relax, and practice the noble art of FT reporting they have cherished for more than a century [11].
But last week, the church also criticized people showing "blanket opposition" to fracking, saying opponents are doing little to help the country's poorest people at a time when fuel resources are scarce and costs are increasing.
Even though for health economic evaluation the utilization of accurate utility data for QoL assessments is critical, in Germany age-specific utility data for healthy but also for the most indications are scarce since cost-utility analyses do not have the relevance in decision-making in Germany as in other countries.
